SCHEMBL7304074

SCHEMBL7304074

CCn1c(=O)c2[nH]c(/C=C/c3ccc(OC)cc3OC)nc2n(CC)c1=O

nearest known ligand 0.68

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ SIRT1 Q96EB6 1/20 0.48
▸ SIRT3 Q9NTG7 1/20 0.48
▸ SIRT5 Q9NXA8 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7304080 1.00 SIRT1 (0.48) SIRT1SIRT3SIRT5
SCHEMBL7732472 0.91 ADORA2A (0.57) —
SCHEMBL7732475 0.91 ADORA2A (0.57) —
SCHEMBL7304617 0.86 KDM4E (0.52) —
SCHEMBL7304607 0.86 KDM4E (0.52) —
SCHEMBL7301077 0.84 — —
SCHEMBL7301088 0.84 — —
SCHEMBL7307276 0.84 — —
SCHEMBL7307283 0.84 — —
SCHEMBL7304841 0.83 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0628311-B1 Xanthine-Derivatives as Antidepressants KYOWA HAKKO KOGYO KK (JP) 2002-04-24 — — EP disclosed
EP-0590919-B1 Therapeutic agents for parkinson's disease KYOWA HAKKO KOGYO KK (JP) 1999-12-29 — — EP disclosed
US-5587378-A ADMINISTERING A SUBSTITUTED XANTHINE COMPOUND KYOWA HAKKO KOGYO CO., LTD. (JP) 1996-12-24 — — US disclosed
US-5543415-A ADMINISTERING A XANTHINE DERIVATIVE KYOWA HAKKO KOGYO CO., LTD. (JP) 1996-08-06 — — US disclosed
US-5484920-A XANTHINE DERIVATIVES KYOWA HAKKO KOGYO CO., LTD. (JP) 1996-01-16 — — US disclosed
EP-0628311-A1 ANTIDEPRESSANT KYOWA HAKKO KOGYO CO., LTD. (JP) 1994-12-14 — — EP disclosed
EP-0590919-A1 Therapeutic agents for parkinson's disease KYOWA HAKKO KOGYO CO., LTD. (JP) 1994-04-06 — — EP disclosed
Send feedback